Abstract
Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43% to 67% in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.
Original language | English (US) |
---|---|
Pages (from-to) | 1304-1307 |
Number of pages | 4 |
Journal | Clinical Infectious Diseases |
Volume | 57 |
Issue number | 9 |
DOIs | |
State | Published - Nov 1 2013 |
Keywords
- clinical laboratory techniques
- Clostridium difficile
- incidence
- nucleic acid amplification techniques
- surveillance
ASJC Scopus subject areas
- Infectious Diseases
- Microbiology (medical)